A new analysis adds to existing evidence showing that recommended childhood immunizations do not increase the risk of autism spectrum disorder (ASD). Despite a 2004 review from the Institute of Medicine that concluded the measles, mumps, rubella, and thimerosal-containing vaccines… Read More ›
Giving patients with allergic rhinitis or asthma a daily dose of allergens under the tongue appears to be an effective option to help desensitize them to respiratory allergens, according to a review published in JAMA today. Patients who experience respiratory… Read More ›
Concern that a front-line class of immunosuppressant drugs used to treat rheumatoid arthritis might increase a patient’s risk of developing herpes zoster (shingles) appears to be unfounded, according to research appearing today in JAMA. Shingles, caused by a reactivation of… Read More ›
Acellular pertussis vaccines, which have become favored over whole-cell pertussis vaccines because they are associated with fewer adverse events, may offer children less protection from pertussis, according to a study published in JAMA today. Ongoing pertussis outbreaks in the United… Read More ›
Milk-protein residue may slip past the standard test used to detect it in processed foods, according to new research. As a result, millions of young children with milk allergy could unknowingly be exposed to milk proteins that will make them… Read More ›
![Individuals who have antibodies to the JC virus are at greater risk of developing a progressive multifocal encephalopathy when taking natalizumab, according to the US Food and Drug Administration. (Image: Arch Neurol. 2002;59[12]:1930-1936](http://newsatjama.files.wordpress.com/2012/01/1-23-12-jcvirus3.jpg?w=120&h=120&crop=1)
Patients who test positive for antibodies to the JC virus (JCV) are at elevated risk for developing a deadly viral illness called progressive multifocal leukoencephalopathy (PML) while taking natalizumab (brand name Tysabri), a drug used to treat multiple sclerosis and… Read More ›
A new study estimates that more than 32 million people in the United States have antibodies that can attack the body’s own tissues, potentially resulting in inflammation and autoimmune diseases, such as type 1 diabetes, lupus, and rheumatoid arthritis. The… Read More ›
By building family trees of specific genes, researchers have discovered how certain antibodies mature from weak foes to powerful defenders that block HIV from infecting immune system cells in the body. The findings offer important clues in the search for… Read More ›
More women are experiencing strokes during pregnancy or shortly after delivery, according to a study published today in the journal Stroke. The researchers used data from the Nationwide Inpatient Sample, the largest collection of nationwide data on hospitalizations, to compare… Read More ›
The same treatment that may have saved lives during the 1918 influenza pandemic could be an effective tool in treating 2009 influenza A(H1N1). New findings published online in Clinical Infectious Diseases suggest that convalescent plasma treatment could reduce deaths from… Read More ›
